It will be interesting to study a synergistic effect of Forskolin and PDE4 inhibitors on the pathophysiology of ALS-FTD which might be effective in much lower doses pharmacologically and well tolerated treatment option without much side effects for this challenging neurodegenerative disorder. The gene discussed is PDE4A; the disease is amyotrophic lateral sclerosis.